A feasibility double-blind trial of levothyroxine vs. levothyroxine-liothyronine in postsurgical hypothyroidism
ContextDespite normalization of Thyrotropin (TSH), some patients with hypothyroidism treated with Levothyroxine (LT4) report residual symptoms which may be attributable to loss of endogenous triiodothyronine (T3).ObjectiveFeasibility trial LT4/liothyronine (LT3) combination vs. LT4/placebo in post-s...
Saved in:
| Main Authors: | Giao Q. Phan, Sahzene Yavuz, Angeliki M. Stamatouli, Ritu Madan, Shanshan Chen, Amelia C. Grover, Naris Nilubol, Pablo Bedoya, Cory Trankle, Roshanak Markley, Antonio Abbate, Francesco S. Celi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1522753/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial
by: F. Azizi, et al.
Published: (2025-07-01) -
Differentiation Between Clinical and Subclinical Hypothyroidism in Pathophysiology, Symptoms, Diagnosis and Treatment – A Narrative Review
by: Mustafa Mohammed Albassam, et al.
Published: (2024-09-01) -
Are liquid levothyroxine formulations comparable? The LETI study
by: Elisa Gatta, et al.
Published: (2025-04-01) -
Quality by design driven RP-HPLC method optimization for analysis of levothyroxine and liothyronine in bulk and tablet dosage form
by: Ramdas Darade, et al.
Published: (2025-04-01) -
ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism
by: Marco Centanni, et al.
Published: (2025-07-01)